Article

Rheumatology Network's Top 5: August 13, 2022

Author(s):

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending August 13, 2022.

Rheumatoid Arthritis Quiz: RA and Flu Vaccination

With seasonal flu vaccinations fast approaching, how much do you know about how rheumatoid arthritis and its treatment affects administration of this vaccine? Test your knowledge with this quiz.

Rheumatoid Arthritis Quiz: Vaccinating Patients Taking Immunosuppressive Medications

Immunosuppressive medication can interfere with the immune response to vaccines, so treatment may need to be held or the timing or type of vaccinations amended. Test your knowledge of vaccinating rheumatoid arthritis patients taking immunosuppressive therapies in this quiz.

Risankizumab Improves Skin, Joint Symptoms in Psoriatic Arthritis

Over the course of 16 weeks, patients with psoriatic arthritis (PsA) receiving risankizumab reported improved joint and skin symptoms when compared with placebo. Improvements were maintained long-term, and the drug was well tolerated with no new safety issues.

Exercise and Behavioral Approaches Reduce Fatigue in Rheumatic Diseases

Exercise and behavioral techniques can be helpful, but they are not often implemented because their effectiveness is unknown and regular face-to-face sessions are undesirable.

Osteoclasts in Patients With PsA, RA Show Functional Differences

Results from a small study suggest that psoriatic arthritis and rheumatoid arthritis osteoclasts might retain some of their immune cell functions during differentiation.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.